Revuforj savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Revuforj

We didn’t find one.

Ask your pharmacy for Revuforj’s cash price, and one or two other pharmacies too.
Revuforj’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameRevuforj

Authorized genericrevumenib

Regular genericrevumenib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Revuforj?

The original

–

Brand nameThe maker’s card

Revuforj Copay Program (SyndAccess)

Savings card from Syndax Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

In the maker’s words

“pay as little as $0 per prescription. No income restrictions apply.”

From the maker’s offer on syndaccess.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Revuforj itself, from the same company, sold without the brand name, and usually for less. For now Revuforj is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

REVUFORJ is a menin inhibitor indicated for:

the treatment of relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation as determined by an FDA-authorized test in adult and pediatric patients 1 year and older.
the treatment of relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 (NPM1 ) mutation in adult and pediatric patients 1 year and older who have no satisfactory alternative treatment options.

Source: the FDA label for Revuforj (Syndax Pharmaceuticals, Inc.), February 4, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/revuforj/